TargetAdvanced glycosylation end product-specific receptor(Homo sapiens (Human))
Vtv Therapeutics
US Patent
Vtv Therapeutics
US Patent
Affinity DataKd: 12.7nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Homo sapiens (Human))
Vtv Therapeutics
US Patent
Vtv Therapeutics
US Patent
Affinity DataKd: 219nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Homo sapiens (Human))
Vtv Therapeutics
US Patent
Vtv Therapeutics
US Patent
Affinity DataKd: 22.3nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Homo sapiens (Human))
Vtv Therapeutics
US Patent
Vtv Therapeutics
US Patent
Affinity DataKd: 99.8nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Homo sapiens (Human))
Vtv Therapeutics
US Patent
Vtv Therapeutics
US Patent
Affinity DataKd: 9.70nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Homo sapiens (Human))
Vtv Therapeutics
US Patent
Vtv Therapeutics
US Patent
Affinity DataKd: 9.80nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair
TargetAdvanced glycosylation end product-specific receptor(Homo sapiens (Human))
Vtv Therapeutics
US Patent
Vtv Therapeutics
US Patent
Affinity DataKd: 257nMAssay Description:The binding affinity of COMPOUND I and compounds of the invention to human sRAGE (the soluble extracellular domain of the human receptor for advanced...More data for this Ligand-Target Pair